Eli Lilly and Company (LLY)

221.30
+0.80(+0.36%)
  • Volume:
    51
  • Bid/Ask:
    220.70/221.40
  • Day's Range:
    220.70 - 221.90
  • Type:Equity
  • Market:Germany
  • ISIN:US5324571083
  • WKN:858560

LLY Overview

Prev. Close
220.5
Day's Range
220.7-221.9
Revenue
-
Open
221.9
52 wk Range
118.12-236.1
EPS
-
Volume
51
Market Cap
198.74B
Dividend (Yield)
2.93
(1.24%)
Average Vol. (3m)
808
P/E Ratio
41.77
Beta
-
1-Year Change
79.85%
Shares Outstanding
906,592,393
Next Earnings Date
-
What is your sentiment on Eli Lilly and Company?
or
Vote to see community's results!

Eli Lilly and Company Company Profile

Employees
35000

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin’s lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; MiNA Therapeutics Limited; Verge Genomics; and The Banner Alzheimer's Institute, as well as Kumquat Biosciences. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellNeutralStrong Buy
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Buy
SummaryNeutralStrong SellStrong SellSellStrong Buy
  • This stock should get back to ASAP in 10 days
    0
    • The U.S. FDA has granted Eli Lilly (LLY) and Boehringer Ingelheim's Jardiance Breakthrough Therapy designation as an investigational treatment for adults with heart failure with...
      0
      • sell the news event like nobodies business. of course they tag it with 56k price tag.
        1
        • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
          0
          • 184 should be the bottom....
            0
            • 180?
              0
            • 10
              0
          • duddddddd
            0
            • Tomorrow up 5 percent minimum. stock up
              1
              • I think the people selling should consider getting in the trial for donanemab.
                1
                • what problem?
                  0
                  • Breakout coming . 220+ coming
                    0
                    • Just in: Lilly has reached another milestone in our fight against the pandemic. The @US_FDA has granted Emergency Use Authorization for another Lilly antibody therapy to treat mild to moderate #COVID19 in high-risk patients. Learn more: e.lilly/2Ndy3Ha
                      0
                      • Let’s go again 🚀🚀🚀 target 300
                        1
                        • sold at 218 bye bye
                          1
                          • mustard rayon 1-29 it briefly hit its record high of 218 them dropped sharply
                            0
                          • hilarious if you lie check the prices before please.
                            0
                          • question fo you see the previous page does it say 53 week range 117.06 to hello 218 hello biff are you there or did they fo a bad lobotomy
                            0
                        • should go up well see
                          0
                          • overall a terrible day
                            0
                            • predictions look real good
                              1
                              • will earnings be good
                                0
                                • Today the plans ???? Target !?
                                  0
                                  • I bought some of Lly, should I not have. I'm still learning.
                                    0
                                    • You did very good😊Goes up😊
                                      0
                                  • back to 150. The report was base on small percentage of people. Other pharmaceutical have about the same early record and end up failing.
                                    4
                                    • as usual
                                      0
                                    • so short it and lose all your money
                                      0
                                  • Today we’re announcing positive Phase 2 #clinicaltrial data for a potential treatment to fight #Alzheimers disease. Learn more: e.lilly/3i3NInL
                                    0
                                    • Huge bubble, S&P PE @39!! scarly , its just next to the 2008! BE COUTIONS!
                                      3
                                      • Mmmm scarly crouton bubbles.
                                        0
                                    • Eli Lilly and Co. will buy Prevail Therapeutics Inc. in a cash deal for approximately $1.04 billion.
                                      0
                                      • Walking dead stock
                                        3
                                        • MP stock on the rise
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.